| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |